ViRexx & AltaRex Announce National Merit Award For Founder.EDMONTON, Alberta -- ViRexx Medical Corp. (TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension VENTURE:VIR VIR Virtual VIR Virgin Islands (ISO Country code) VIR Virginia International Raceway VIR Vascular and Interventional Radiology VIR Vehicle Inspection Report VIR Virtual Interface (Alteon) ) & AltaRex Medical Corp. (TSX:ALT) are pleased to announce that founder and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Dr. Antoine Noujaim, has received the BioNorth 2004 National Merit Award presented by the Ottawa Life Sciences Council ("OLSC OLSC Override, Limit & Status Check OLSC Ontario Library Services Centre (Kitchener, Canada) "). The award recognizes outstanding individual achievement in Canada 's life sciences sector. Dr. Noujaim accepted the award at the BioNorth 2004 Annual OLSC Achievement Awards Dinner at the Ottawa Congress Centre on Tuesday, November 30th, 2004. Dr. Noujaim is a Professor Emeritus of the University of Alberta. He has been involved in the startup of several biotechnology companies, and is the founder, President and CEO of ViRexx and AltaRex. Dr. Noujaim was also the co-founder of Biomira Inc. He currently serves on numerous corporate and scientific advisory boards and is an inventor on over 100 pending and issued patents. About ViRexx ViRexx is an Edmonton, Alberta based biotechnology company focused on the development of novel and unique therapeutic products for the treatment of chronic Hepatitis Chronic hepatitis Long lasting inflammation of the liver due to viruses or other causes. Mentioned in: Tube Compression of the Esophagus and Stomach chronic hepatitis B, Hepatitis C and selected solid tumors. For additional information, please visit www.virexx.com. About AltaRex AltaRex Medical Corp. is focused on the research, development and commercialization of foreign antibodies that modulate the immune system for the treatment of certain cancers and other diseases where there exists an unmet medical need. Additional information about AltaRex Medical Corp. can be found on its website at www.altarex.com. NEITHER THE TSX NOR THE TSX VENTURE EXCHANGE TSX Venture Exchange Originally called the Canadian Venture Exchange (CDNX), this was a result of the merger of the Vancouver and Alberta stock exchanges. The goal of TSX Venture Exchange is to provide venture companies with effective access to capital while protecting investors. HAS APPROVED OR DISAPPROVED OF THE INFORMATION CONTAINED HEREIN |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion